STE

STE

USD

STERIS plc (Ireland) Ordinary Shares

$225.000-0.610 (-0.270%)

Precio en Tiempo Real

Healthcare
Dispositivos médicos
Estados Unidos

Gráfico de Precios

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$225.610

Máximo

$225.905

Mínimo

$222.860

Volumen

0.06M

Fundamentos de la Empresa

Capitalización de Mercado

22.2B

Industria

Dispositivos médicos

País

United States

Estadísticas de Negociación

Volumen Promedio

0.56M

Bolsa

NYQ

Moneda

USD

Rango de 52 Semanas

Mínimo $200.98Actual $225.000Máximo $248.24

Informe de Análisis de IA

Última actualización: 26 abr 2025
Generado por IAFuente de Datos: Yahoo Finance, Bloomberg, SEC

STERIS plc (STE): What's Happening with the Stock and What to Watch

Stock Symbol: STE Generate Date: 2025-04-26 23:00:54

Okay, let's break down what's been going on with STERIS plc stock lately. We'll look at the recent news, how the price has been moving, and what some predictions are saying.

Recent News Buzz

Three news items popped up recently. One is pretty standard stuff – STERIS announced they'll hold a conference call on May 15th to go over their financial results for the past fiscal year. Earnings calls are always a big deal because they give investors a look under the hood at how the company is actually performing.

Beyond that, we saw a couple of analyst opinions. JMP Securities reiterated their "Market Outperform" rating on the stock and kept their price target at $265. That's a positive signal; it means they think the stock should do better than the overall market and has room to climb from where it is now. On the flip side, Needham reiterated their "Hold" rating, which is more of a neutral stance – basically saying, "If you own it, keep it; if you don't, maybe wait and see."

So, the news is a bit mixed, leaning slightly positive thanks to that higher price target from JMP, but nothing earth-shattering. The main thing on the horizon is definitely that May 15th earnings call.

Price Check: What the Stock's Been Doing

Looking back at the last month or so, the price action for STE has been pretty interesting, and frankly, a bit choppy. In late March, the stock was trading mostly in the $220s. Then, in early April, it took a noticeable tumble, dipping below $210 for a moment. But it didn't stay down long, bouncing back sharply around April 9th. Since that bounce, it's been trading mostly in a range, roughly between $220 and $226. The last price we have is sitting right around $225. It hasn't been a smooth trend up or down; there's been some volatility in there.

What the AI Thinks

We also have a short-term prediction from an AI model. It's forecasting a bit of a dip in the immediate future. The prediction suggests a small decrease today, followed by larger percentage drops over the next couple of days. So, the AI is seeing some potential weakness right around the corner for the stock price.

Putting It All Together: Outlook & Ideas

So, where does all this leave us? We've got analysts with differing views (one bullish, one neutral), a stock price that's recovered from a recent dip but has been trading sideways, and an AI predicting a short-term slide. The company's own recommendation data highlights some strong technical signals and analyst optimism, which sounds good, but it also points out some fundamental weaknesses (like lower growth and higher debt) and notes that negative AI prediction.

It's a picture with conflicting signals. The technical indicators and one analyst suggest potential for the stock to move higher, possibly towards that $265 target eventually. But the AI prediction for the next few days is negative, the fundamentals aren't stellar, and the upcoming earnings call is a big unknown that could swing things either way.

Given this mixed bag, especially with earnings coming up, a cautious approach seems reasonable. However, if you're looking at potential moves based on the technical strength and the analyst's positive view, the data suggests that buying on a slight dip, perhaps if the price pulls back towards the $224-$225 area, could be something to consider.

If you decide to jump in, managing your risk is key. A potential stop-loss level noted in the data is around $217.95. This is below that recent dip area and could help limit losses if the stock price falls significantly. On the upside, a potential take-profit level is suggested around $229.39, which is near recent highs and could be a place to consider selling if the stock climbs.

Just remember, the AI is calling for a short-term drop, and those earnings results on May 15th are a major event that could override everything else we've discussed.

Company Snapshot

Just for context, STERIS is a major player in the Healthcare sector, specifically focused on Medical Devices and infection prevention. They provide equipment and services used in hospitals and by medical device manufacturers. So, the health of the healthcare industry and hospital spending trends are really important for this company.


Disclaimer: This analysis is based on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can go down as well as up. You should always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Noticias Relacionadas

GlobeNewswire

STERIS to Host a Conference Call for Fiscal 2025 Fourth Quarter and Full Year Financial Results on May 15, 2025

DUBLIN, IRELAND, April 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE:STE) ("STERIS" or the "Company") announced today that it will host a conference call to discuss its fiscal 2025 fourth quarter and full year

Ver más
STERIS to Host a Conference Call for Fiscal 2025 Fourth Quarter and Full Year Financial Results on May 15, 2025
Analyst Upgrades

JMP Securities Reiterates Market Outperform on Steris, Maintains $265 Price Target

JMP Securities analyst David Turkaly reiterates Steris with a Market Outperform and maintains $265 price target.

Ver más
JMP Securities Reiterates Market Outperform on Steris, Maintains $265 Price Target
Analyst Upgrades

Needham Reiterates Hold on Steristo Hold

Needham analyst Mike Matson reiterates Steris from Hold to Hold.

Ver más
Needham Reiterates Hold on Steristo Hold

Predicción de IABeta

Recomendación de IA

Bajista

Actualizado el: 27 abr 2025, 19:02

BajistaNeutralAlcista

63.6% Confianza

Riesgo y Negociación

Nivel de Riesgo3/5
Riesgo Medio
Adecuado Para
Conservador
Guía de Negociación

Punto de Entrada

$223.72

Toma de Ganancias

$229.39

Stop Loss

$217.95

Factores Clave

PDI 6.4 está por encima de MDI 3.8 con ADX 11.0, lo que sugiere una tendencia alcista
El precio actual está extremadamente cerca del nivel de soporte ($224.21), lo que sugiere una fuerte oportunidad de compra
El volumen de operaciones es 5.6 veces el promedio (5,949), lo que indica una presión de compra extremadamente fuerte
El MACD 0.1606 está por encima de la línea de señal 0.1035, lo que indica un cruce alcista

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.